JP2019505500A5 - - Google Patents

Download PDF

Info

Publication number
JP2019505500A5
JP2019505500A5 JP2018532429A JP2018532429A JP2019505500A5 JP 2019505500 A5 JP2019505500 A5 JP 2019505500A5 JP 2018532429 A JP2018532429 A JP 2018532429A JP 2018532429 A JP2018532429 A JP 2018532429A JP 2019505500 A5 JP2019505500 A5 JP 2019505500A5
Authority
JP
Japan
Prior art keywords
hydroxy
carboxamide
benzoxazole
phenyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018532429A
Other languages
English (en)
Japanese (ja)
Other versions
JP6927589B2 (ja
JP2019505500A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/077914 external-priority patent/WO2017108282A1/en
Publication of JP2019505500A publication Critical patent/JP2019505500A/ja
Publication of JP2019505500A5 publication Critical patent/JP2019505500A5/ja
Application granted granted Critical
Publication of JP6927589B2 publication Critical patent/JP6927589B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018532429A 2015-12-22 2016-11-16 哺乳類ヒストンデアセチラーゼ活性の阻害剤として有用な二環式ヒドロキサム酸 Expired - Fee Related JP6927589B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15201841.2 2015-12-22
EP15201841 2015-12-22
PCT/EP2016/077914 WO2017108282A1 (en) 2015-12-22 2016-11-16 Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity

Publications (3)

Publication Number Publication Date
JP2019505500A JP2019505500A (ja) 2019-02-28
JP2019505500A5 true JP2019505500A5 (https=) 2019-12-19
JP6927589B2 JP6927589B2 (ja) 2021-09-01

Family

ID=55068815

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018532429A Expired - Fee Related JP6927589B2 (ja) 2015-12-22 2016-11-16 哺乳類ヒストンデアセチラーゼ活性の阻害剤として有用な二環式ヒドロキサム酸

Country Status (11)

Country Link
US (1) US10654814B2 (https=)
EP (1) EP3394052B1 (https=)
JP (1) JP6927589B2 (https=)
KR (1) KR20180098593A (https=)
CN (1) CN108602812B (https=)
AU (1) AU2016375634B2 (https=)
CA (1) CA3007025A1 (https=)
ES (1) ES2893099T3 (https=)
RU (1) RU2747431C2 (https=)
WO (1) WO2017108282A1 (https=)
ZA (1) ZA201804568B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201946624A (zh) * 2018-05-09 2019-12-16 新旭生技股份有限公司 雜芳基化合物及其用途
KR20210068399A (ko) * 2018-08-06 2021-06-09 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 주니어 유니버시티 신경퇴행성 질병의 치료를 위한 피피에이알지씨1알파 활성제로서 2-아릴벤즈이미다졸
JP7447080B2 (ja) 2018-08-08 2024-03-11 ブリストル-マイヤーズ スクイブ カンパニー Pad4阻害剤としての置換チエノピロール
MX2021001565A (es) 2018-08-08 2021-04-19 Bristol Myers Squibb Co Inhibidores tipo indol y azaindol de enzimas peptidil arginina deiminasas (pad).
KR102146741B1 (ko) * 2018-10-31 2020-08-21 계명대학교 산학협력단 항바이러스 조성물
US20220008414A1 (en) * 2018-11-23 2022-01-13 Chong Kun Dang Pharmaceutical Corp. Pharmaceutical composition comprising histone deacetylase 6 inhibitors
MX2022007376A (es) 2019-12-20 2022-09-02 Tenaya Therapeutics Inc Fluoroalqull-oxadiazoles y sus usos.
TW202140477A (zh) 2020-02-12 2021-11-01 美商必治妥美雅史谷比公司 雜環pad4抑制劑
JP2023530788A (ja) * 2020-06-08 2023-07-19 アンジー ファーマシューティカル カンパニー リミテッド 選択的hdac6阻害剤として有用なキナゾリン誘導体
CN112516142B (zh) * 2020-12-11 2021-10-15 北京华氏精恒医药科技有限公司 一种具有hdac抑制活性的药物组合物、制备方法及其用途
IL307883A (en) 2021-04-23 2023-12-01 Tenaya Therapeutics Inc HDAC6 inhibitors for use in the treatment of dilated myocardial disease
US20240252502A1 (en) 2021-05-04 2024-08-01 Tenaya Therapeutics, Inc. Hdac6 inhibitors for treatment of metabolic disease and hfpef
CN114409638B (zh) * 2022-02-09 2023-02-14 深圳大学 组蛋白去乙酰化酶8选择性降解剂、制备方法及其在抗肿瘤活性中的应用
EP4494640A4 (en) * 2022-03-17 2026-05-06 Univ Sookmyung Womens Ind Acad Coop Found Novel heterocyclic inhibitor for histone deacetylase, and pharmaceutical composition comprising same
WO2025160629A1 (en) * 2024-01-31 2025-08-07 Certa Therapeutics Pty Ltd Proton sensing gpcr modulators
WO2025215092A1 (en) 2024-04-10 2025-10-16 Institut National de la Santé et de la Recherche Médicale Selective hdac6 inhibitors for use in the treatment of myotonic dystrophy type 1
CN118459418B (zh) * 2024-04-26 2025-04-08 河北中医药大学 一种异羟肟酸类hdac抑制剂及其在制备抗肿瘤药物中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861533B2 (en) 2001-11-23 2005-03-01 Irm Llc Solution phase sythesis of arylbenzoxazoles
WO2005028447A1 (en) * 2003-09-22 2005-03-31 S*Bio Pte Ltd Benzimidazole derivates: preparation and pharmaceutical applications
ZA200602181B (en) * 2003-09-22 2007-06-27 S Bio Pte Ltd Benzimidazole derivatives: Preparation and pharmaceutical applications
US20050137234A1 (en) * 2003-12-19 2005-06-23 Syrrx, Inc. Histone deacetylase inhibitors
ITFI20050041A1 (it) * 2005-03-15 2006-09-16 Menarini Internat Operations Luxembourg Sa Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono
ES2441196T3 (es) 2007-04-18 2014-02-03 Kissei Pharmaceutical Co., Ltd. Derivado de anillo condensado nitrogenado, composiciones farmacéuticas que lo contienen, y su uso con fines médicos
WO2008129276A1 (en) 2007-04-19 2008-10-30 Boehringer Ingelheim International Gmbh Disulfonamides useful in the treatment of inflammation
CN101918389A (zh) 2007-11-02 2010-12-15 梅特希尔基因公司 组蛋白脱乙酰酶抑制剂
UA103013C2 (uk) 2007-12-06 2013-09-10 Тиботек Фармасьютикелз Амідні сполуки як активатори противірусних препаратів
CA2875549A1 (en) 2008-04-15 2009-10-22 Pharmacyclics, Inc. Selective inhibitors of histone deacetylase
WO2010061903A1 (ja) 2008-11-27 2010-06-03 塩野義製薬株式会社 Pi3k阻害活性を有するピリミジン誘導体およびピリジン誘導体
WO2012012322A1 (en) 2010-07-19 2012-01-26 Millennium Pharmaceuticals, Inc. Substituted hydroxamic acids and uses thereof
WO2014015088A1 (en) 2012-07-19 2014-01-23 Bristol-Myers Squibb Company Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase
KR20160055170A (ko) 2013-08-30 2016-05-17 암비트 바이오사이언시즈 코포레이션 바이아릴 아세트아미드 화합물 및 이의 사용 방법
JP6392888B2 (ja) * 2014-03-12 2018-09-19 チョン クン ダン ファーマシューティカル コーポレーション ヒストン脱アセチル化酵素6阻害剤としての新規化合物およびこれを含む薬剤学的組成物
WO2015188015A1 (en) * 2014-06-04 2015-12-10 Haro Pharmaceutical Inc. 18-20 member bi-polycyclic compounds
CA2984971A1 (en) * 2015-05-11 2016-11-17 Kancera Ab Benzimidazole derivates useful as inhibitors of mammalian histone deacetylase activity

Similar Documents

Publication Publication Date Title
JP2019505500A5 (https=)
RU2747431C2 (ru) Бициклические гидроксамовые кислоты, полезные в качестве ингибиторов активности деацетилазы гистонов млекопитающих
JP7264060B2 (ja) 二環式化合物および癌の処置におけるそれらの使用
JP6412148B2 (ja) 自己免疫疾患治療のためのピラゾール
KR102781404B1 (ko) 통합 스트레스 경로의 조정제
US10864196B2 (en) Modulators of the integrated stress pathway
JP7307057B2 (ja) 統合的ストレス経路の調節剤
US10357484B2 (en) Heterocyclic compound
BR112020008827A2 (pt) moduladores da via de estresse integrada
WO2016031815A1 (ja) 複素環化合物
WO2017033946A1 (ja) 複素環化合物
JPWO2015002230A1 (ja) アミド化合物
CA3090485C (en) Heterobicyclic carboxylic acids for treating cancer or inflammatory diseases
HK40029801A (en) Heterobicyclic carboxylic acids for treating cancer or inflammatory diseases
US20200181128A1 (en) 3-hydroxy-imidazolidin-4-one compounds as inhibitors of indoleamine 2,3-dioxygenase